Basic Information
Basic information for SOX2-OT-283-29aa
Peptide Name SOX2-OT-283-29aa
Genome Position chr3:181563838-181563924[+]
Species Human
Peptide Sequence MPEAARKRSLTFRNLSRGSTLWIETKIIL
Peptide Length 29
Unique No (SOX2-OT-201-29aa,SOX2-OT-204-29aa,SOX2-OT-205-29aa,SOX2-OT-212-29aa,SOX2-OT-214-29aa,SOX2-OT-215-29aa,SOX2-OT-216-29aa,SOX2-OT-218-29aa,SOX2-OT-221-29aa,SOX2-OT-224-29aa,SOX2-OT-226-29aa,SOX2-OT-228-29aa,SOX2-OT-230-29aa,SOX2-OT-241-29aa,SOX2-OT-245-29aa,SOX2-OT-255-29aa,SOX2-OT-256-29aa,SOX2-OT-268-29aa,SOX2-OT-271-29aa,SOX2-OT-273-29aa,SOX2-OT-275-29aa,SOX2-OT-282-29aa,SOX2-OT-285-29aa,SOX2-OT-286-29aa,SOX2-OT-289-29aa,SOX2-OT-291-29aa,SOX2-OT-293-29aa,SOX2-OT-295-29aa,SOX2-OT-299-29aa,SOX2-OT-300-29aa,SOX2-OT-301-29aa,SOX2-OT-303-29aa,SOX2-OT-304-29aa)
Grand Average of Hydropathicity -0.231
Relative Molecular Mass 3893.5
Experimental Evidences 2:lncORF,ribo
lncRNA ID/Name ENSG00000242808;SOX2-OT
Transcript ID/Name ENST00000646698;SOX2-OT-283
Transcript Length 4109
Coding Ability 0.3052
DNA Sequence Corresponding to Peptide ATGCCAGAAGCCGCTAGAAAAAGAAGTTTGACATTCAGAAACTTATCAAGAGGTTCTACTCTTTGGATAGAGACCAAAATCATACTT
Experimental Evidences
   lncORF
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :